Invention Grant
US08946218B2 CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments
有权
CCR2受体拮抗剂，其制备方法及其作为药物的用途
- Patent Title: CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments
- Patent Title (中): CCR2受体拮抗剂，其制备方法及其作为药物的用途
-
Application No.: US13696860Application Date: 2011-05-10
-
Publication No.: US08946218B2Publication Date: 2015-02-03
- Inventor: Heiner Ebel , Sara Frattini , Riccardo Giovannini , Christoph Hoenke , Rocco Mazzaferro , Stefan Scheuerer
- Applicant: Heiner Ebel , Sara Frattini , Riccardo Giovannini , Christoph Hoenke , Rocco Mazzaferro , Stefan Scheuerer
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Edward S. Lazer
- Priority: EP10162627 20100512
- International Application: PCT/EP2011/057550 WO 20110510
- International Announcement: WO2011/141477 WO 20111117
- Main IPC: C07D401/14
- IPC: C07D401/14 ; A61K31/506 ; C07D413/14 ; C07D401/06 ; C07D405/14
Abstract:
The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD and pain diseases.
Public/Granted literature
- US20130090338A1 NEW CCR2 RECEPTOR ANTAGONISTS, METHOD FOR PRODUCING THE SAME, AND USE THEREOF AS MEDICAMENTS Public/Granted day:2013-04-11
Information query
